Lesson 5 - Measuring Quality of Life in Lung Disease
By Patricia P. Katz, PhD
Read/Print This Document
Poststudy Questions
Dr. Katz is Associate Professor of Medicine and Health Policy, University of California, San Francisco, California.
Dr. Katz has disclosed no significant relationships with the companies/organizations whose products or services may be discussed within this chapter.
Lesson 6 - Asbestos-Related Lung Disease
By Arjun B. Chatterjee, MD, MS, FCCP; and Jill A. M. Ohar, MD, FCCP
Read/Print This Document
Poststudy Questions
Dr. Chatterjee is Assistant Professor of Medicine and Dr. Ohar is Medical Director, Wake Forest University School of Medicine, Section on Pulmonary, Critical Care, Allergy, and Immunologic Diseases, Winston-Salem, North Carolina.
Dr. Chatterjee has disclosed significant relationships with the following companies/organizations whose products or services may be discussed within this chapter:
- Expert medical opinion to Simmons Cooper Law Firm
- Expert medical opinion to Wallace & Graham Law Firm
Dr. Ohar has disclosed significant relationships with the following companies/organizations whose products or services may be discussed within this chapter:
- Expert medical opinion to Simmons Cooper Law Firm
- Expert medical opinion to Wallace & Graham Law Firm
- Expert medical opinion to Weitz and Luxenberg
- Expert medical opinion to Walker & Wylder
